Coppola, Paolo E.; Gaibani, Paolo; Sartor, Chiara; Ambretti, Simone; Lewis, Russell E.; Sassi, Claudia; Pignatti, Marco; Paolini, Stefania; Curti, Antonio; Castagnetti, Fausto; Ursi, Margherita; Cavo, Michele; Stanzani, Marta, Ceftolozane-Tazobactam Treatment of Hypervirulent Multidrug Resistant Pseudomonas aeruginosa Infections in Neutropenic Patients, «MICROORGANISMS», 2020, 8, pp. 1 - 11 [articolo]Open Access
Lolli G.; Broccoli A.; Stefoni V.; Argnani L.; Leone O.; Cavo M.; Zinzani P.L., Chronic lymphocytic leukemia focus in the context of a cardiac mass in a pretreated patient: an exceptional incidental finding, «TUMORI», 2020, 106, pp. 29 - 32 [articolo]
Passamonti, Francesco; Cattaneo, Chiara; Arcaini, Luca; Bruna, Riccardo; Cavo, Michele; Merli, Francesco; Angelucci, Emanuele; Krampera, Mauro; Cairoli, Roberto; Della Porta, Matteo Giovanni; Fracchiolla, Nicola; Ladetto, Marco; Gambacorti Passerini, Carlo; Salvini, Marco; Marchetti, Monia; Lemoli, Roberto; Molteni, Alfredo; Busca, Alessandro; Cuneo, Antonio; Romano, Alessandra; Giuliani, Nicola; Galimberti, Sara; Corso, Alessandro; Morotti, Alessandro; Falini, Brunangelo; Billio, Atto; Gherlinzoni, Filippo; Visani, Giuseppe; Tisi, Maria Chiara; Tafuri, Agostino; Tosi, Patrizia; Lanza, Francesco; Massaia, Massimo; Turrini, Mauro; Ferrara, Felicetto; Gurrieri, Carmela; Vallisa, Daniele; Martelli, Maurizio; Derenzini, Enrico; Guarini, Attilio; Conconi, Annarita; Cuccaro, Annarosa; Cudillo, Laura; Russo, Domenico; Ciambelli, Fabrizio; Scattolin, Anna Maria; Luppi, Mario; Selleri, Carmine; Ortu La Barbera, Elettra; Ferrandina, Celestino; Di Renzo, Nicola; Olivieri, Attilio; Bocchia, Monic, Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study, «THE LANCET. HAEMATOLOGY», 2020, 7, pp. 737 - 745 [articolo]
Di Bacco A.; Bahlis N.J.; Munshi N.C.; Avet-Loiseau H.; Masszi T.; Viterbo L.; Pour L.; Ganly P.; Cavo M.; Langer C.; Kumar S.K.; Rajkumar S.V.; Keats J.J.; Berg D.; Lin J.; Li B.; Badola S.; Shen L.; Zhang J.; Esseltine D.-L.; Luptakova K.; van de Velde H.; Richardson P.G.; Moreau P., c-MYC expression and maturity phenotypes are associated with outcome benefit from addition of ixazomib to lenalidomide-dexamethasone in myeloma, «EUROPEAN JOURNAL OF HAEMATOLOGY», 2020, 105, pp. 35 - 46 [articolo]Open Access
Cavo M.; Dimopoulos M.A.; San-Miguel J.; Mateos M.-V.; Jakubowiak A.; Deraedt W.; Lam A.; Kampfenkel T.; Qi M.; He J., Comparative Efficacy of Bortezomib, Melphalan, and Prednisone (VMP) With or Without Daratumumab Versus VMP Alone in the Treatment of Newly Diagnosed Multiple Myeloma: Propensity Score Matching of ALCYONE and VISTA Phase III Studies, «CLINICAL LYMPHOMA MYELOMA & LEUKEMIA», 2020, 20, pp. 480 - 489 [articolo]
Parasrampuria D.A.; He J.; Zhang L.; Muresan B.; Hu P.; Nemat S.; Hashim M.; Lam A.; Appiani C.; Cavo M.; Dimopoulos M.A.; San-Miguel J.; Mateos M.-V., Comparison of efficacy from two different dosing regimens of bortezomib: an exposure–response analysis, «BRITISH JOURNAL OF HAEMATOLOGY», 2020, 189, pp. 860 - 868 [articolo]
Tura, Sante; Cavo, Michele; Zinzani, Pier Luigi; Broccoli, Alessandro; Argnani, Lisa; Fiacchini, Mauro, Corso di malattie del sangue e degli organi emolinfopoietici, in: Capitolo 9: Il metodo della ricerca clinica, Bologna, Società Editrice Esculapio srl, 2020, pp. 617 - 621 [capitolo di libro]
Tura, Sante; Cavo, Michele; Zinzani, Pier Luigi; Broccoli, Alessandro, Corso di malattie del sangue e degli organi emolinfopoietici, Bologna, Società Editrice Esculapio srl, 2020, pp. 631 . [libro]
Weisel K.; Spencer A.; Lentzsch S.; Avet-Loiseau H.; Mark T.M.; Spicka I.; Masszi T.; Lauri B.; Levin M.-D.; Bosi A.; Hungria V.; Cavo M.; Lee J.-J.; Nooka A.; Quach H.; Munder M.; Lee C.; Barreto W.; Corradini P.; Min C.-K.; Chanan-Khan A.A.; Horvath N.; Capra M.; Beksac M.; Ovilla R.; Jo J.-C.; Shin H.-J.; Sonneveld P.; Casneuf T.; Deangelis N.; Amin H.; Ukropec J.; Kobos R.; Mateos M.-V., Daratumumab, bortezomib, and dexamethasone in relapsed or refractory multiple myeloma: Subgroup analysis of CASTOR based on cytogenetic risk, «JOURNAL OF HEMATOLOGY & ONCOLOGY», 2020, 13, Article number: 115, pp. 1 - 11 [articolo]Open Access
Landgren, C Ola; Chari, Ajai; Cohen, Yael C; Spencer, Andrew; Voorhees, Peter; Estell, Jane A; Sandhu, Irwindeep; Jenner, Matthew W; Williams, Catherine; Cavo, Michele; van de Donk, Niels W C J; Beksac, Meral; Moreau, Philippe; Goldschmidt, Hartmut; Kuppens, Steven; Bandekar, Rajesh; Clemens, Pamela L; Neff, Tobias; Heuck, Christoph; Qi, Ming; Hofmeister, Craig C, Daratumumab monotherapy for patients with intermediate-risk or high-risk smoldering multiple myeloma: a randomized, open-label, multicenter, phase 2 study (CENTAURUS), «LEUKEMIA», 2020, 0, pp. 0 - 0 [articolo]Open Access
Hungria V.; Martinez-Banos D.M.; Mateos M.-V.; Dimopoulos M.A.; Cavo M.; Heeg B.; Garcia A.; Lam A.; Machnicki G.; He J.; Fernandez M., Daratumumab Plus Bortezomib, Melphalan, and Prednisone Versus Standard of Care in Latin America for Transplant-Ineligible Newly Diagnosed Multiple Myeloma: Propensity Score Matching Analysis, «ADVANCES IN THERAPY», 2020, 37, pp. 4996 - 5009 [articolo]Open Access
Mateos, Maria-Victoria; Spencer, Andrew; Nooka, Ajay K; Pour, Ludek; Weisel, Katja; Cavo, Michele; Laubach, Jacob P; Cook, Gordon; Iida, Shinsuke; Benboubker, Lotfi; Usmani, Saad Z; Yoon, Sung-Soo; Bahlis, Nizar J; Chiu, Christopher; Ukropec, Jon; Schecter, Jordan M; Qin, Xiang; O'Rourke, Lisa; Dimopoulos, Meletios A, Daratumumab-based regimens are highly effective and well tolerated in relapsed or refractory multiple myeloma regardless of patient age: subgroup analysis of the phase 3 CASTOR and POLLUX studies, «HAEMATOLOGICA», 2020, 105, pp. 468 - 477 [articolo]Open Access
Goldschmidt H.; Dimopoulos M.A.; Rajkumar S.V.; Weisel K.C.; Moreau P.; Chng W.-J.; Mikala G.; Cavo M.; Ramasamy K.; Suryanarayan K.; Teng Z.; Labotka R.; Mateos M.V., Deepening responses associated with improved progression-free survival with ixazomib versus placebo as posttransplant maintenance in multiple myeloma, «LEUKEMIA», 2020, 34, pp. 3019 - 3027 [articolo]Open Access
Salvestrini V.; Ciciarello M.; Pensato V.; Simonetti G.; Laginestra M.A.; Bruno S.; Pazzaglia M.; De Marchi E.; Forte D.; Orecchioni S.; Martinelli G.; Bertolini F.; Mendez-Ferrer S.; Adinolfi E.; Di Virgilio F.; Cavo M.; Curti A., Denatonium as a Bitter Taste Receptor Agonist Modifies Transcriptomic Profile and Functions of Acute Myeloid Leukemia Cells, «FRONTIERS IN ONCOLOGY», 2020, 10, Article number: 1225, pp. 1 - 17 [articolo]Open Access
Bonifazi F.; Barbato F.; Ravaioli F.; Sessa M.; Defrancesco I.; Arpinati M.; Cavo M.; Colecchia A., Diagnosis and Treatment of VOD/SOS After Allogeneic Hematopoietic Stem Cell Transplantation, «FRONTIERS IN IMMUNOLOGY», 2020, 11, Article number: 489, pp. 489 - 489 [articolo]Open Access
